Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 24391-24400 Newer>

The Motley Fool July 11, 2007 Brian Orelli	Everybody Loves RNAi Roche is the latest firm to (over)pay for the hottest new drug technology. Alnylam announced that it licensed some of its intellectual property to Roche for $331 million. Investors, take note.
The Motley Fool July 11, 2007 Tom Taulli	Foolish Dealbook: CDW Programs a Deal The tech distributor gives investors a nice present. Here's a look at the $7.3 billion transaction that will take CDW private.
The Motley Fool July 10, 2007 Sham Gad	HDFC Vaults Skyward The Indian bank is growing and poised to get even bigger. Investors, take note.
The Motley Fool July 10, 2007 Brian Lawler	Adolor Tries Again Adolor continues work on its second drug candidate. Investors will have to wait until early 2008 for some data to sink their teeth into.
The Motley Fool July 10, 2007 Nathan Parmelee	Quick Take: Danone's Pricey Purchase What is Danone up to with its big purchase of Dutch baby-food maker Numico? Shareholders tend to react unkindly to poor capital allocation decisions.
The Motley Fool July 10, 2007 Ryan Fuhrmann	Foolish Forecast: The Shoe Fits at Wolverine The shoe maker is set to report its second-quarter earnings shortly. Investors, here's what to expect.
The Motley Fool July 10, 2007 Alyce Lomax	Can Kijiji Outclass Craigslist? eBay will have quite a moat to cross if it wants to challenge Craigslist. Savvy Web users love Craigslist for the free -- and therefore completely disruptive -- services it provides. Investors, take note.
The Motley Fool July 10, 2007 Ryan Fuhrmann	Put Pepsi Bottling on Ice Results at Pepsi Bottling are going down easy for investors, but PepsiCo is even more appealing. Investors, here's why.
The Motley Fool July 10, 2007 Rick Aristotle Munarriz	Cheesecake Can Be Good for You Cheesecake Factory keeps growing, thanks to its second growth vehicle. Comps inched 1.1% higher, powered by a 5.7% increase at Grand Lux.
The Motley Fool July 10, 2007 Steven Mallas	Oily Outlook for WD-40? WD-40 misses earnings expectations and reduces its outlook for the year. Should you still buy the stock?
<Older 24391-24400 Newer> Return to current articles.